E C Keystone

813 total citations
30 papers, 581 citations indexed

About

E C Keystone is a scholar working on Rheumatology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, E C Keystone has authored 30 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 6 papers in Pathology and Forensic Medicine and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in E C Keystone's work include Rheumatoid Arthritis Research and Therapies (8 papers), Systemic Lupus Erythematosus Research (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). E C Keystone is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Systemic Lupus Erythematosus Research (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). E C Keystone collaborates with scholars based in Canada, United States and Japan. E C Keystone's co-authors include Murray Baron, Geoff Littlejohn, Murray B. Urowitz, Geoffrey Littlejohn, H A Smythe, Victor Fornasier, Arthur Bookman, Reuven Mader, B. Haraoui and Vivian P. Bykerk and has published in prestigious journals such as Radiology, Infection and Immunity and Annals of the Rheumatic Diseases.

In The Last Decade

E C Keystone

29 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E C Keystone Canada 16 275 176 139 104 98 30 581
Carmen G. Espinoza United States 18 163 0.6× 126 0.7× 130 0.9× 108 1.0× 127 1.3× 28 626
Nina Birdi Canada 11 196 0.7× 147 0.8× 226 1.6× 67 0.6× 87 0.9× 14 571
M H Miller Australia 9 160 0.6× 184 1.0× 200 1.4× 116 1.1× 76 0.8× 12 543
B Chouvet France 15 135 0.5× 213 1.2× 163 1.2× 71 0.7× 100 1.0× 64 646
J. Fraga Spain 15 132 0.5× 133 0.8× 217 1.6× 73 0.7× 72 0.7× 62 558
Huei-Huang Ho Taiwan 13 400 1.5× 93 0.5× 271 1.9× 235 2.3× 118 1.2× 23 696
A. Cosnes France 18 349 1.3× 289 1.6× 375 2.7× 95 0.9× 63 0.6× 47 848
Takaya Fukumoto Japan 14 256 0.9× 160 0.9× 102 0.7× 126 1.2× 30 0.3× 57 596
B. Catteau France 17 130 0.5× 113 0.6× 230 1.7× 101 1.0× 47 0.5× 50 719
Wolfgang Meyer Germany 15 162 0.6× 263 1.5× 265 1.9× 170 1.6× 67 0.7× 52 635

Countries citing papers authored by E C Keystone

Since Specialization
Citations

This map shows the geographic impact of E C Keystone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E C Keystone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E C Keystone more than expected).

Fields of papers citing papers by E C Keystone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E C Keystone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E C Keystone. The network helps show where E C Keystone may publish in the future.

Co-authorship network of co-authors of E C Keystone

This figure shows the co-authorship network connecting the top 25 collaborators of E C Keystone. A scholar is included among the top collaborators of E C Keystone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E C Keystone. E C Keystone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Emery, Paul, Peter C. Taylor, M. Weinblatt, et al.. (2017). Microarray Pathway Analysis Comparing Baricitinib and Adalimumab in Moderate to Severe Rheumatoid Arthritis Patients, from a Phase 3 Study. Oxford University Research Archive (ORA) (University of Oxford). 69. 2 indexed citations
3.
Taylor, Peter C., E C Keystone, D. van der Heijde, et al.. (2015). Baricitinib Versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to Background Methotrexate Therapy: Results of a Phase 3 Study. Data Archiving and Networked Services (DANS). 67. 8–8. 15 indexed citations
4.
Keystone, E C, F. C. Breedveld, D. van der Heijde, et al.. (2013). Long-Term Impact of Delaying Combination Therapy With Adalimumab Plus Methotrexate By 2 Years in Patients With Early Rheumatoid Arthritis: Final 10-Year Results of the Premier Trial. Data Archiving and Networked Services (DANS). 65. 1 indexed citations
5.
Choy, T. C., V. Bykerk, Gilles Boire, et al.. (2013). Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort. Lara D. Veeken. 53(3). 482–490. 8 indexed citations
6.
Emery, Paul, D. van der Heijde, Mikkel Østergaard, et al.. (2011). Magnetic resonance imaging assessments of patients with RA and their association with clinical and radiographic outcomes. Annals of the Rheumatic Diseases. 70. 1 indexed citations
7.
Keystone, E C, F. C. Breedveld, Arthur Kavanaugh, et al.. (2009). Sustained clinical remission and response for early RA patients with adalimumab and methotrexate initial combination therapy: 5-year results of the PREMIER trial.. Data Archiving and Networked Services (DANS). 36(11). 2598–2598. 1 indexed citations
8.
Mease, Philip J., K E F Hobbs, Andrew Chalmers, et al.. (2008). Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor α antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study. Annals of the Rheumatic Diseases. 68(8). 1247–1254. 66 indexed citations
9.
Buskila, Dan, G. T. D. Thomson, Manuela Poletto Klein, & E C Keystone. (1992). Avascular necrosis of bone mimicking symmetric polyarthritis in a patient with malignant lymphoma treated with high-dose steroids.. PubMed. 28(11). 804–5. 1 indexed citations
10.
Thomson, G. T. D., et al.. (1990). Erythema nodosum and non-Hodgkin's lymphoma.. PubMed. 17(3). 383–5. 14 indexed citations
11.
Bookman, Arthur, et al.. (1986). Nifedipine in the treatment of idiopathic Raynaud's syndrome.. PubMed. 13(2). 331–6. 26 indexed citations
12.
Ascah, Kathryn J., Robert H. Hyland, Michael Hutcheon, et al.. (1984). Invasive aspergillosis in a "healthy" patient.. PubMed. 131(4). 332–5. 24 indexed citations
13.
Fornasier, Victor, Geoffrey Littlejohn, Murray B. Urowitz, E C Keystone, & H A Smythe. (1983). Spinal entheseal new bone formation: the early changes of spinal diffuse idiopathic skeletal hyperostosis.. PubMed. 10(6). 939–47. 38 indexed citations
14.
Littlejohn, Geoff & E C Keystone. (1982). The association of retroperitoneal fibrosis with systemic vasculitis and HLA-B27: a case report and review of the literature.. PubMed. 8(4). 665–9. 46 indexed citations
15.
Littlejohn, Geoff & E C Keystone. (1981). Eosinophilic fasciitis and aplastic anaemia.. PubMed. 7(5). 730–2. 24 indexed citations
16.
Littlejohn, Geoffrey, Murray B. Urowitz, H A Smythe, & E C Keystone. (1981). Radiographic features of the hand in diffuse idiopathic skeletal hyperostosis (DISH): comparison with normal subjects and acromegalic patients.. Radiology. 140(3). 623–629. 30 indexed citations
17.
Keystone, E C, et al.. (1980). Effect of T-cell deficiency on the chronicity of arthritis induced in mice by Mycoplasma pulmonis. Infection and Immunity. 27(1). 192–196. 17 indexed citations
18.
Tenenbaum, J, Murray B. Urowitz, E C Keystone, Isaac L. Dwosh, & J. E. Curtis. (1979). Leucapheresis in severe rheumatoid arthritis.. Annals of the Rheumatic Diseases. 38(1). 40–44. 36 indexed citations
19.
Taylor, G. Michael, D Taylor‐Robinson, & E C Keystone. (1978). Effects of lymecycline on Mycoplasma pulmonis-induced arthritis in mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 59(2). 204–12. 11 indexed citations
20.
Broder, I., Reuben Baumal, & E C Keystone. (1968). Studies into the occurrence of soluble antigen-antibody complexes in disease. II. Criteria for distinguishing soluble complexes from other macromolecular histamine releasers.. PubMed. 3(6). 537–53. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026